Innovassynth Technologies (India) Ltd
533315Innovassynth Technologies (India) Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: Domestic institutions moved −2.1 points over 8 quarters while the operating story went the other way — someone close to the numbers is not convinced.
The price is in a confirmed uptrend (15 weeks in). Underneath, the last four quarters read improving. What settles it: whether the register turns back in the story’s favour.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Innovassynth Technologies (India) Ltd trades at ₹143, in a confirmed uptrend and 15 weeks into that stage. That is +73.2% against its own 200-day average. It sits at 100% of a 52-week range of ₹64 to ₹143. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 13 straight weeks.
Today the stock is in a confirmed uptrend — week 15 of stage 2, confirmed. At ₹143 it trades +73.2% versus its 200-day average and sits at 100% of its 52-week range (₹64–₹143).
Against the market, two honest reads. Cumulative: over the last 5 months the stock moved +100% while the NIFTY 500 moved −1% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 13 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Innovassynth Technologies (India) Ltd trades at 45.6× P/E, against too little history to rank. Its long-run median P/E is 27.8×, measured across 0.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 45.6× is against too little history to rank, against a long-run median of 27.8× measured over 0.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read.
Innovassynth Technologies (India) Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 4 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
4-Factor Sector Score
47.1/100 — rank 5 of 5 in Chemicals - Speciality · 49% evidence confidence · provisional, ranked below fully-evidenced peers
Innovassynth Technologies (India) Ltd scores 47.1 out of 100 against the 5 companies it is compared with in Chemicals - Speciality, ranking 5. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 18.4 + 6.2 + 10 + 12.5 = 47.1. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Innovassynth Technologies (India) Ltd reported ₹56.0 Cr of revenue in the Jun 26 quarter, +356.3% year on year. The last full year, FY26, came in at ₹102 Cr. The last four reported quarters add to ₹146 Cr. A multi-year compound rate is not shown because the annual history behind it is too short to compute one honestly.
FY26 revenue came in at ₹102 Cr (null on the year). The latest quarter (Jun 26) printed ₹56.0 Cr, +356.3% year on year.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Innovassynth Technologies (India) Ltd's operating margin is 26.7% in the Jun 26 quarter, +153.4 percentage points against the same quarter a year ago.
The latest quarter's operating margin is 26.7%, +153.4 pp against the same quarter a year ago. Across 2 fiscal years the operating margin has ranged −24.0%–22.0%.
Why the margin moved: operating margin went +153.4 pp year on year while gross margin went +6.1 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Innovassynth Technologies (India) Ltd earned ₹6.7 Cr of net profit in the Jun 26 quarter. The full FY26 year was a loss of ₹29.0 Cr. That is 12.0% of the quarter's revenue. The same quarter a year earlier lost ₹18.7 Cr. 9 of the last 12 reported quarters were loss-making.
Jun 26 profit was ₹6.7 Cr, null year on year. On the full year, FY26 printed ₹−29.0 Cr (null).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Innovassynth Technologies (India) Ltd's cash-flow history is too thin to judge how much reported profit converts into cash. In FY26 that was ₹−39.0 Cr of operating cash against ₹−29.0 Cr of profit. After ₹142 Cr of capital spending, ₹−181 Cr was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
FY26: operating cash of ₹−39.0 Cr against reported profit of ₹−29.0 Cr, leaving free cash of ₹−181 Cr after ₹142 Cr of capital spending.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Innovassynth Technologies (India) Ltd does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran ₹142 Cr over the last 3 years. Averaged over those years that is 46.4% of FY26 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of ₹142 Cr over the last 3 fiscal years against ₹8.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹4.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Innovassynth Technologies (India) Ltd earns a ROCE of −25% in FY26. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is −28.4% net margin on 0.37× asset turns.
FY26 ROCE is −25%.
Why the return is what it is — the wiring (FY26): −28.4% net margin × 0.37× asset turns × 2.96× balance-sheet leverage ≈ −31.1% on equity. Margin does its share; leverage is a meaningful part of the equation.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Innovassynth Technologies (India) Ltd carries ₹113 Cr of borrowings against ₹94.0 Cr of equity in FY26, a debt-to-equity of 1.20. Operating profit covers the interest bill −3×. Over 5 years borrowings went from ₹2.0 Cr to ₹113 Cr. Capital spending ran ₹142 Cr across the last 3 of those years.
FY26: borrowings of ₹113 Cr against equity of ₹94.0 Cr — a debt-to-equity of 1.20. Operating profit covers the interest bill −3×. Over 5 years borrowings went from ₹2.0 Cr to ₹113 Cr while capital spending ran ₹142 Cr in just the last 3 — part of the build-out is riding on borrowed money.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters added 43.6 points of Innovassynth Technologies (India) Ltd over 8 quarters, the biggest move on the register. That takes promoters to 75.0% of the company. Domestic institutions moved −2.1 points over the same window, to 1.1%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +43.6 points over 8 quarters to 75.0%; Domestic institutions: −2.1 points over 8 quarters to 1.1%; Foreign institutions: +1.1 points over 8 quarters to 1.1%.
Why the register moved: promoters drove it (+43.6 points), absorbed on the other side by domestic institutions (−2.1 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Innovassynth Technologies (India) Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Jubilant Agri & Consumer Products LtdJUBLCPL | 57.3/100Mixed-positive evidence84% evidence | BREAKING OUT | 19.9/35 Revenue 19.9% · PAT 22.6% · OPM change -1 pp 100% evidence | 15.2/25 ROCE 40.4% · OPM 13% 100% evidence | 15.0/20 P/E 24.1× · PEG 0.49 50% evidence | 7.2/20 RS sector -29% · RS bench 3.3% · 1Y -26.5%6 of 10 weeks ahead 70% evidence |
| Exact sum: 19.9 + 15.2 + 15 + 7.2 = 57.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Chembond Chemicals LtdCHEMBONDCH | 56.6/100Mixed-positive evidence62% evidence | BREAKING OUT | 20.0/35 Revenue 18.4% · PAT 19.7% · OPM change 0.2 pp 95% evidence | 14.1/25 ROCE 23.6% · OPM 13.1% 95% evidence | 10.0/20 P/E 18.4× · PEG — 0% evidence | 12.5/20 RS sector — · RS bench 48.7% · 1Y —6 of 6 weeks ahead 25% evidence |
| Exact sum: 20 + 14.1 + 10 + 12.5 = 56.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Anlon Healthcare LtdAHCL | 53.8/100Mixed-positive evidence71% evidence | TURNING | 20.6/35 Revenue 95.4% · PAT 66.6% · OPM change -0.9 pp 95% evidence | 12.1/25 ROCE 20.8% · OPM 17.8% 95% evidence | 10.0/20 P/E 32.9× · PEG — 0% evidence | 11.1/20 RS sector -1.6% · RS bench 42% · 1Y 112.3%7 of 12 weeks ahead 70% evidence |
| Exact sum: 20.6 + 12.1 + 10 + 11.1 = 53.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Sudeep Pharma LtdSUDEEPPHRM | 51.2/100Mixed-positive evidence70% evidence | BREAKING OUT | 18.5/35 Revenue 23.2% · PAT 20.9% · OPM change 0 pp 100% evidence | 17.7/25 ROCE 28.2% · OPM 35% 100% evidence | 5.0/20 P/E 74.4× · PEG 4.75 50% evidence | 10.0/20 RS sector — · RS bench — · 1Y —12 of 12 weeks ahead 0% evidence |
| Exact sum: 18.5 + 17.7 + 5 + 10 = 51.2 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 5Innovassynth Technologies (India) Ltdthis page533315 | 47.1/100Thin evidence · provisional49% evidence | BREAKING OUT | 18.4/35 Revenue 100% · PAT 66.7% · OPM change 153.4 pp 71% evidence | 6.2/25 ROCE -24.9% · OPM 26.7% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.5/20 RS sector — · RS bench 64% · 1Y —9 of 9 weeks ahead 25% evidence |
| Exact sum: 18.4 + 6.2 + 10 + 12.5 = 47.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Innovassynth Technologies (India) Ltd's share price today?
Innovassynth Technologies (India) Ltd trades at ₹143. The company is valued at ₹1,325 Cr. The stock sits at the very top of its 52-week range (₹64–₹143), +73.2% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 15 weeks in. — as of 11 September 2026.
What were Innovassynth Technologies (India) Ltd's latest quarterly results?
Innovassynth Technologies (India) Ltd reported revenue of ₹56.0 Cr and net profit of ₹6.7 Cr for the Jun 26 quarter. Earnings per share were ₹0.73. The operating margin was 26.7%, 153.4 pp higher than a year earlier. — as of 11 September 2026.
What is Innovassynth Technologies (India) Ltd's revenue?
Innovassynth Technologies (India) Ltd reported revenue of ₹56.0 Cr in the Jun 26 quarter, +356.3% year on year. For the full FY26 fiscal year, revenue was ₹102 Cr. — as of 11 September 2026.
What is Innovassynth Technologies (India) Ltd's profit?
Innovassynth Technologies (India) Ltd earned ₹6.7 Cr of net profit in the Jun 26 quarter. Full-year FY26 profit was ₹−29.0 Cr. The operating margin ran 26.7% in the latest quarter. — as of 11 September 2026.
What is Innovassynth Technologies (India) Ltd's market cap?
Innovassynth Technologies (India) Ltd's market capitalisation is ₹1,325 Cr at a share price of ₹143. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.
Does Innovassynth Technologies (India) Ltd pay a dividend?
No — Innovassynth Technologies (India) Ltd has recorded a dividend payout of 0% of profit in each of its last 12 reported fiscal years, so there is no payout history to quote. That is a reading of the filed annual statements, not an estimate. — as of 11 September 2026.
How is Innovassynth Technologies (India) Ltd performing?
Innovassynth Technologies (India) Ltd is in a confirmed uptrend, 15 weeks in. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 13 weeks. This describes what the data did, not a rating. — as of 11 September 2026.
Is Innovassynth Technologies (India) Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 15 of stage 2), trading +73.2% versus its 200-day average and at the very top of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.
Is Innovassynth Technologies (India) Ltd beating the market?
On recent form, yes — Innovassynth Technologies (India) Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 13 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 5 months the stock moved +100% against the NIFTY 500's −1% — ahead of the index over the full window. — as of 11 September 2026.
Will Innovassynth Technologies (India) Ltd's share price go up?
This page publishes no price forecast for Innovassynth Technologies (India) Ltd. What it measures instead: the share price is ₹143, the price is in a confirmed uptrend 15 weeks in. Direction is not something this site claims to know. — as of 11 September 2026.
Who owns Innovassynth Technologies (India) Ltd?
Promoters hold 75.0% of Innovassynth Technologies (India) Ltd, foreign institutions 1.1%, domestic institutions 1.1% and the public 22.7% (latest quarter). The biggest move on the register over the last two years: Promoters added 43.6 points over 8 quarters. — as of 11 September 2026.
Does Innovassynth Technologies (India) Ltd have too much debt?
It carries real leverage — Innovassynth Technologies (India) Ltd's debt-to-equity is 1.20, and operating profit covers the interest bill −3×. FY26 borrowings were ₹113 Cr against equity of ₹94.0 Cr. Read the returns on this page with that leverage in mind — as of 11 September 2026.
What is Innovassynth Technologies (India) Ltd's capex?
Innovassynth Technologies (India) Ltd spent ₹142 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹142 Cr, with ₹4.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.
What is Innovassynth Technologies (India) Ltd's cash flow?
Innovassynth Technologies (India) Ltd consumed ₹39.0 Cr of operating cash in FY26 — cash flowed out rather than in (free cash flow: ₹−181 Cr). Reported profit that year was ₹−29.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 11 September 2026.
Where is Innovassynth Technologies (India) Ltd in its business cycle?
Innovassynth Technologies (India) Ltd's FY26 operating margin was −24.0%, against a 2-year band of −24.0%–22.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 26.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.
What could break the Innovassynth Technologies (India) Ltd story?
The sharpest disagreement: Domestic institutions moved −2.1 points over 8 quarters while the operating story went the other way — someone close to the numbers is not convinced. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.
Is Innovassynth Technologies (India) Ltd a stock worth studying right now?
This is not investment advice. The machine read: Innovassynth Technologies (India) Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether the register turns back in the story’s favour. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.
Not SEBI Registered !! Not Investment advice !!